Eloxx Pharmaceuticals, Inc.

ELOX · OTC · SIC 2836: Biological Products, (No Diagnostic Substances)
389
SEC Filings

Business Summary

Eloxx Pharmaceuticals, Inc. is a pharmaceutical company filing a comprehensive Annual Report covering fiscal years 2023, 2024, and 2025 as part of efforts to become current in SEC filing obligations. The filing represents their first periodic SEC submission since a Form 10-Q filed November 13, 2023. Specific products, services, and business operations are not described in the provided Item 1 excerpt.

Next Earnings

Q2 FY2026 — expected 2026-08-14

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionELOXdiscussed_in_filing Healthcare & Bio
topic_mentionELOXdiscussed_in_filing Healthcare & Bio
topic_mentionELOXdiscussed_in_filing Healthcare & Bio
topic_mentionELOXdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-172025-12-310001193125-26-108687EDGAR110K words
2023-03-312022-12-310000950170-23-011360EDGAR—
2022-03-302021-12-310001564590-22-012683EDGAR—
2021-03-122020-12-310001564590-21-012703EDGAR—
2020-03-062019-12-310001564590-20-009148EDGAR—
2019-03-142018-12-310001564590-19-007811EDGAR—
2018-03-162017-12-310001193125-18-086028EDGAR—
2017-10-132017-06-300001144204-17-052475EDGAR—
2016-10-132016-06-300001144204-16-128038EDGAR—
2015-10-092015-06-300001144204-15-058919EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2023-11-132023-09-300000950170-23-062940EDGAR48K words
2023-08-112023-06-300000950170-23-041837EDGAR—
2023-05-122023-03-310000950170-23-021821EDGAR—
2022-11-102022-09-300000950170-22-024490EDGAR—
2022-08-122022-06-300001564590-22-029339EDGAR—
2022-05-062022-03-310001564590-22-018586EDGAR—
2021-11-082021-09-300001564590-21-055313EDGAR—
2021-08-162021-06-300001564590-21-044626EDGAR—
2021-05-072021-03-310001564590-21-025356EDGAR—
2020-11-062020-09-300001564590-20-051711EDGAR—
2020-08-072020-06-300001564590-20-038092EDGAR—
2020-05-082020-03-310001564590-20-023543EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2025-08-120001104659-25-076933EDGAR1K words
2024-10-170001104659-24-109521EDGAR—
2024-07-160001104659-24-080251EDGAR—
2024-03-290001104659-24-041148EDGAR—
2024-03-140001104659-24-034529EDGAR—
2024-01-090001104659-24-002631EDGAR—
2023-12-280001104659-23-130052EDGAR—
2023-12-150001104659-23-126400EDGAR—
2023-11-130001104659-23-117308EDGAR—
2023-10-160001104659-23-109423EDGAR—

389 total filings indexed. 357 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001035354
TickerELOX
ExchangeOTC
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 2a16fe6366475f165c96cc468fcabb181f4215478986e7e2bd2ae47eb389d609
parent: b947c83b4f77470d76f23318ff82b43960f32910013768a03edd0cfdbe52bbc0
content hash: ab6b251d04149544b63697a8a1cb226b28f72206f4acff399195fff0c43c03cd
signed: 2026-04-13T04:44:50.020Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf